| TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness S Rossi, M Cordella, C Tabolacci, G Nassa, D D’Arcangelo, C Senatore, ... Journal of Experimental & Clinical Cancer Research 37, 1-17, 2018 | 97 | 2018 |
| Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications G Nassa, G Giurato, G Cimmino, F Rizzo, M Ravo, A Salvati, TA Nyman, ... Scientific reports 8 (1), 498, 2018 | 81 | 2018 |
| Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells G Nassa, A Salvati, R Tarallo, V Gigantino, E Alexandrova, D Memoli, ... Science advances 5 (2), eaav5590, 2019 | 76 | 2019 |
| Precision and personalized medicine: how genomic approach improves the management of cardiovascular and neurodegenerative disease O Strianese, F Rizzo, M Ciccarelli, G Galasso, Y D’Agostino, A Salvati, ... Genes 11 (7), 747, 2020 | 72 | 2020 |
| The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading R Tarallo, G Giurato, G Bruno, M Ravo, F Rizzo, A Salvati, L Ricciardi, ... Genome biology 18, 1-27, 2017 | 67 | 2017 |
| The histone methyltransferase DOT1L is a functional component of estrogen receptor alpha signaling in ovarian cancer cells A Salvati, V Gigantino, G Nassa, G Giurato, E Alexandrova, F Rizzo, ... Cancers 11 (11), 1720, 2019 | 31 | 2019 |
| Histone methyltransferase DOT1L as a promising epigenetic target for treatment of solid tumors E Alexandrova, A Salvati, G Pecoraro, J Lamberti, V Melone, A Sellitto, ... Frontiers in Genetics 13, 864612, 2022 | 28 | 2022 |
| PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach D D'Arcangelo, F Facchiano, G Nassa, A Stancato, A Antonini, S Rossi, ... Oncotarget 7 (47), 77257, 2016 | 28 | 2016 |
| Quantitative mapping of RNA-mediated nuclear estrogen receptor β interactome in human breast cancer cells G Giurato, G Nassa, A Salvati, E Alexandrova, F Rizzo, TA Nyman, ... Scientific data 5 (1), 1-9, 2018 | 26 | 2018 |
| BRCA methylation testing identifies a subset of ovarian carcinomas without germline variants that can benefit from PARP inhibitor N Sahnane, I Carnevali, G Formenti, J Casarin, S Facchi, R Bombelli, ... International journal of molecular sciences 21 (24), 9708, 2020 | 22 | 2020 |
| The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei G Nassa, G Giurato, A Salvati, V Gigantino, G Pecoraro, J Lamberti, ... Scientific data 6 (1), 173, 2019 | 22 | 2019 |
| Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis V Melone, A Salvati, D Palumbo, G Giurato, G Nassa, F Rizzo, L Palo, ... Journal of Translational Medicine 20 (1), 306, 2022 | 16 | 2022 |
| Global view of candidate therapeutic target genes in hormone-responsive breast cancer A Salvati, V Gigantino, G Nassa, V Mirici Cappa, GM Ventola, ... International journal of molecular sciences 21 (11), 4068, 2020 | 15 | 2020 |
| The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma B Montico, G Giurato, G Pecoraro, A Salvati, A Covre, F Colizzi, A Steffan, ... Molecular oncology 16 (3), 565-593, 2022 | 14 | 2022 |
| Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy B Montico, F Colizzi, G Giurato, A Rizzo, A Salvati, L Baboci, D Benedetti, ... Cell Death & Disease 11 (5), 392, 2020 | 13 | 2020 |
| Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant … A Salvati, V Melone, A Sellitto, F Rizzo, R Tarallo, TA Nyman, G Giurato, ... Breast Cancer Research 24 (1), 52, 2022 | 7 | 2022 |
| LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer M Casarotto, V Lupato, G Giurato, R Guerrieri, S Sulfaro, A Salvati, ... Clinical Epigenetics 14 (1), 171, 2022 | 6 | 2022 |
| Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment C Selleri, N Montuori, A Salvati, B Serio, A Pesapane, P Ricci, A Gorrasi, ... Oncotarget 7 (37), 60206, 2016 | 6 | 2016 |
| Identification of Antiestrogen‐Bound Estrogen Receptor α Interactomes in Hormone‐Responsive Human Breast Cancer Cell Nuclei V Gigantino, A Salvati, G Giurato, D Palumbo, O Strianese, F Rizzo, ... Proteomics 20 (19-20), 2000135, 2020 | 5 | 2020 |
| Small non-coding RNA landscape is modified by GPAT2 silencing in MDA-MB-231 cells E Lacunza, MA Montanaro, A Salvati, D Memoli, F Rizzo, MF Henning, ... Oncotarget 9 (46), 28141, 2018 | 5 | 2018 |
